Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 07/11/2016 1:38:49 PM
Post# of 72447
Avatar
Posted By: Drano
Re: sox0407 #25090
Note that Oritavancin has "structural similarity" to existing antibiotics.

Quote:
Pharmacological class: Lipoglycopeptide (structural similarity to vancomycin, teicoplanin and telavancin).



whereas Brilacidin is a totally new class of antibiotics which, by its mechanism, is unlikely to allow bacteria to survive to develop resistance.

Just reminding people of that because some of the morons elsewhere claim there is no need for multiple antibiotics to be available.













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site